Expand SGHT Menu
SGHT MENU

SGHT Latest Press Releases

-- November 11, 2025 --

New Peer-Reviewed Publications Highlight Effectiveness of OMNI Surgical System with TruSync Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans Globe Newswire 7:00 AM

-- November 6, 2025 --

Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance Globe Newswire 4:05 PM
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer Globe Newswire 4:04 PM

-- November 4, 2025 --

Sight Sciences to Present at Two Upcoming Investor Conferences Globe Newswire 4:05 PM

-- October 23, 2025 --

Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025 Globe Newswire 4:05 PM

-- October 17, 2025 --

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare Interventional Dry Eye Procedure Globe Newswire 7:00 AM

-- September 17, 2025 --

Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use Globe Newswire 7:00 AM

-- September 9, 2025 --

Sight Sciences Announces the OMNI Surgical System to be Included in UnitedHealthcare's Expanded Coverage of Glaucoma Surgical Treatments Globe Newswire 7:05 AM

-- September 2, 2025 --

Sight Sciences Announces Recognition of the TearCare System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO Globe Newswire 4:05 PM

-- August 26, 2025 --

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference Globe Newswire 4:05 PM

-- August 7, 2025 --

Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance Globe Newswire 4:05 PM

-- July 30, 2025 --

Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease Globe Newswire 7:00 AM

-- July 29, 2025 --

Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare Procedure for the Treatment of Dry Eye Disease Globe Newswire 7:00 AM

-- July 24, 2025 --

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025 Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes